VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform originating from Imperial College London, today announces a collaboration with AstraZeneca to progress the company’s platform technology through proof ...
Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated subsidiary of ...
The Banook Group, specialized in cardiac safety, clinical imaging and endpoint adjudication, today announces the acquisition of nabios GmbH (Munich). With this first external acquisition, the Banook Group becomes a European leader in the booming ...
Popular Posts
